Oncology pathways cell proliferation. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy32

Cells, Cultured Cell Line, Tumor Cell Line Tumor Cells, Cultured Epithelial Cells T-Lymphocytes Stem Cells Fibroblasts Muscle, Smooth, Vascular Myocytes, Smooth Muscle Endothelial Cells B-Lymphocytes Endothelium, Vascular NIH 3T3 Cells Cell Nucleus Epithelium CD4-Positive T-Lymphocytes Cell Line, Transformed Liver Keratinocytes Intestinal Mucosa Neural Stem Cells Bone Marrow Cells Spleen Glomerular Mesangium Hematopoietic Stem Cells Extracellular Matrix Embryo, Mammalian 3T3 Cells HeLa Cells Tunica Intima Aorta

Organisms13

Mice, Inbred C57BL Mice, Knockout Mice, Nude Mice, Transgenic Mice, Inbred BALB C Rats, Sprague-Dawley Rats, Inbred F344 Rats, Wistar Mice, SCID Cattle Mice, Mutant Strains Animals, Newborn Mice, Inbred Strains

Diseases22

Neoplasms Breast Neoplasms Cell Transformation, Neoplastic Hyperplasia Lung Neoplasms Disease Models, Animal Neovascularization, Pathologic Prostatic Neoplasms Neoplasm Invasiveness Colonic Neoplasms Adenocarcinoma Liver Neoplasms Disease Progression Ovarian Neoplasms Carcinoma Melanoma Brain Neoplasms Carcinoma, Hepatocellular Neoplasm Metastasis Carcinoma, Squamous Cell Pancreatic Neoplasms Glioma

Chemicals and Drugs93

Bromodeoxyuridine RNA, Messenger Proliferating Cell Nuclear Antigen Antineoplastic Agents Ki-67 Antigen RNA, Small Interfering Cyclin D1 Thymidine Transcription Factors Proto-Oncogene Proteins c-akt Cyclin-Dependent Kinase Inhibitor p27 Cell Cycle Proteins DNA Enzyme Inhibitors Growth Inhibitors DNA-Binding Proteins Proto-Oncogene Proteins Extracellular Signal-Regulated MAP Kinases Proto-Oncogene Proteins c-myc Mitogens Cyclin-Dependent Kinase Inhibitor p21 Protein-Serine-Threonine Kinases Mitogen-Activated Protein Kinase 3 Recombinant Proteins Nuclear Proteins Mitogen-Activated Protein Kinase 1 Interleukin-2 Platelet-Derived Growth Factor Tumor Suppressor Protein p53 Fibroblast Growth Factor 2 Growth Substances Phosphatidylinositol 3-Kinases Transforming Growth Factor beta Tumor Suppressor Proteins Neoplasm Proteins Mitogen-Activated Protein Kinases Epidermal Growth Factor Cyclins Receptor, Epidermal Growth Factor MicroRNAs Antibodies, Monoclonal beta Catenin Vascular Endothelial Growth Factor A Trans-Activators Retinoblastoma Protein Antigens, CD Cytokines Protein Kinase Inhibitors DNA Primers Tumor Markers, Biological Intercellular Signaling Peptides and Proteins Oligonucleotides, Antisense TOR Serine-Threonine Kinases Membrane Proteins Intracellular Signaling Peptides and Proteins STAT3 Transcription Factor Carcinogens Insulin-Like Growth Factor I Cisplatin Cyclin-Dependent Kinases Cyclin E Homeodomain Proteins Protein-Tyrosine Kinases Estradiol Proteins Culture Media, Serum-Free Angiogenesis Inhibitors Repressor Proteins Carrier Proteins Cyclin D Culture Media, Conditioned Proto-Oncogene Proteins c-sis Interferon-gamma Cyclin D2 Recombinant Fusion Proteins Proto-Oncogene Proteins c-bcl-2 Antimetabolites Antineoplastic Agents, Phytogenic Protein Isoforms Collagen NF-kappa B ras Proteins Cyclin A Paclitaxel Cyclin-Dependent Kinase 2 Caspase 3 Hedgehog Proteins Doxorubicin Receptors, Estrogen Cyclin-Dependent Kinase 4 Phosphoproteins Wnt Proteins Pyrimidines

Analytical, Diagnostic and Therapeutic Techniques and Equipment36

Immunohistochemistry Blotting, Western Lymphocyte Activation Reverse Transcriptase Polymerase Chain Reaction Flow Cytometry Transfection Cell Count Gene Knockdown Techniques Models, Biological Antineoplastic Combined Chemotherapy Protocols Disease Models, Animal Gene Expression Profiling Mitotic Index Xenograft Model Antitumor Assays In Situ Nick-End Labeling Treatment Outcome Prognosis Real-Time Polymerase Chain Reaction Clinical Trials as Topic Cell Culture Techniques In Situ Hybridization Transplantation, Heterologous Neoplasm Transplantation Oligonucleotide Array Sequence Analysis Coculture Techniques Survival Analysis Neoplasm Staging Immunoenzyme Techniques Immunoblotting Culture Media, Serum-Free Disease-Free Survival Culture Media, Conditioned Fluorescent Antibody Technique Combined Modality Therapy Tumor Burden Survival Rate

Phenomena and Processes53

Cell Proliferation Cell Division Signal Transduction Apoptosis Cell Cycle Cell Differentiation Cell Survival Cell Movement Lymphocyte Activation Phosphorylation Gene Expression Regulation, Neoplastic Dose-Response Relationship, Drug Cell Growth Processes Time Factors Down-Regulation Gene Expression Regulation Transfection Gene Expression Up-Regulation RNA Interference Cell Count Enzyme Activation Mutation Gene Expression Regulation, Developmental Base Sequence Phenotype MAP Kinase Signaling System G1 Phase Cell Adhesion S Phase Mitosis Transcription, Genetic Protein Binding Amino Acid Sequence Wound Healing Cell Cycle Checkpoints Neurogenesis Regeneration Promoter Regions, Genetic Gene Silencing G1 Phase Cell Cycle Checkpoints Drug Synergism G0 Phase Neovascularization, Physiologic Cell Death Genes, myc Kinetics Morphogenesis DNA Replication Liver Regeneration Cell Communication Autocrine Communication Cell Aging

Disciplines and Occupations5

Medical Oncology Oncology Nursing Radiation Oncology Immunohistochemistry Hematology

Information Science4

Molecular Sequence Data Base Sequence Amino Acid Sequence Survival Rate

Health Care9

Oncology Nursing Oncology Service, Hospital Cancer Care Facilities Treatment Outcome Societies, Medical Clinical Trials as Topic Survival Analysis Disease-Free Survival Survival Rate

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Phenomena and Processes Disciplines and Occupations Information Science Health Care

Cell Proliferation Medical Oncology Oncology Nursing Cell Division Radiation Oncology Cells, Cultured Signal Transduction Cell Line, Tumor Apoptosis Oncology Service, Hospital Cell Cycle Cell Differentiation Neoplasms Bromodeoxyuridine RNA, Messenger Immunohistochemistry Cell Survival Cell Movement Cell Line Blotting, Western Proliferating Cell Nuclear Antigen Antineoplastic Agents Lymphocyte Activation Phosphorylation Ki-67 Antigen Mice, Inbred C57BL Reverse Transcriptase Polymerase Chain Reaction Gene Expression Regulation, Neoplastic Tumor Cells, Cultured Dose-Response Relationship, Drug RNA, Small Interfering Cell Growth Processes Time Factors Down-Regulation Flow Cytometry Gene Expression Regulation Epithelial Cells Mice, Knockout T-Lymphocytes Transfection Cyclin D1 Stem Cells Mice, Nude Breast Neoplasms Gene Expression Thymidine Up-Regulation Mice, Transgenic Transcription Factors Fibroblasts Proto-Oncogene Proteins c-akt RNA Interference Cell Count Muscle, Smooth, Vascular Cyclin-Dependent Kinase Inhibitor p27 Mice, Inbred BALB C Molecular Sequence Data Cell Transformation, Neoplastic Enzyme Activation Cell Cycle Proteins DNA Hyperplasia Enzyme Inhibitors Growth Inhibitors DNA-Binding Proteins Proto-Oncogene Proteins Extracellular Signal-Regulated MAP Kinases Proto-Oncogene Proteins c-myc Myocytes, Smooth Muscle Rats, Sprague-Dawley Mitogens Gene Knockdown Techniques Cyclin-Dependent Kinase Inhibitor p21 Mutation Lung Neoplasms Protein-Serine-Threonine Kinases Gene Expression Regulation, Developmental Models, Biological Base Sequence Phenotype Antineoplastic Combined Chemotherapy Protocols MAP Kinase Signaling System Mitogen-Activated Protein Kinase 3 Recombinant Proteins G1 Phase Disease Models, Animal Neovascularization, Pathologic Nuclear Proteins Cancer Care Facilities Gene Expression Profiling Mitogen-Activated Protein Kinase 1 Prostatic Neoplasms Interleukin-2 Platelet-Derived Growth Factor Tumor Suppressor Protein p53 Fibroblast Growth Factor 2 Cell Adhesion Growth Substances Phosphatidylinositol 3-Kinases Transforming Growth Factor beta

No FAQ available that match "oncology pathways cell proliferation"